Results of TETimaX Trial of Langerhans Cell Histiocytosis Treatment and Perspectives on the Role of Imatinib Mesylate in the Era of MAPK SignalingLiliana Montella, Giovannella Palmieri, Mario Giuliano et al.|Biomedicines|2021Cited by 2